Noom Med Review: What GLP-1 Treatment Costs and What to Know

Noom Med is Noom's clinical program for weight loss, pairing prescription medication with the psychology-based coaching and tracking tools in the main Noom app. As of September 11, 2026, its site listed access to brand-name GLP-1 and related medications including Ozempic, Zepbound, Mounjaro, Wegovy and the Wegovy pill, generic liraglutide, metformin and a medication called Foundayo, alongside its own compounded lines sold as Noom GLP-1Rx, Noom GLP-1Rx Plus, Noom Microdose GLP-1Rx and Noom Microdose GLP-1Rx Plus.

Noom states that prescribed medications require a clinical evaluation and that not everyone who applies will qualify for a prescription. Ozempic itself is FDA-approved for type 2 diabetes and other conditions, not for weight loss, and Noom's own page says it may be prescribed off-label for weight loss, meaning it is used for a purpose the FDA has not approved it for.

As of September 11, 2026, Noom's site stated that access to brand-name medication like Ozempic and Zepbound starts at $39, plus any out-of-pocket cost for the medication itself depending on your insurance coverage. Its Ozempic page separately listed $39 to get started, then $129 a month for ongoing care, and stated plainly that the cost of the medication is not included in that subscription price. Noom's own FAQ also said Ozempic typically costs between $900 and $1,000 a month without insurance, varying by your location, pharmacy and coverage.

The cheaper route on Noom's site is compounded medication. The Noom Microdose GLP-1Rx Program, as stated on Noom's site as of September 11, 2026, starts at $79 for an initial three-week subscription plus four weeks of medication, then $179 a month plus tax for a twelve-week subscription after that, with final pricing depending on program selection. That page also states the plan can be canceled anytime, that it is not available in all 50 states, and that this pricing applies to new accounts only, effective July 27, 2026, which means existing account holders may be on different terms.

Compounded medication carries a specific disclosure. Noom's site states that compounded semaglutide offered through its GLP-1Rx programs is produced in an FDA-registered facility but has not been reviewed by the FDA for safety, efficacy or quality. Noom also states that Novo Nordisk is the only U.S. company with FDA-approved semaglutide products (Rybelsus, Ozempic, Wegovy) and Lilly is the only U.S. company with FDA-approved tirzepatide products (Zepbound, Mounjaro). Separately, Noom's own disclosure states that metformin is not FDA-approved for weight loss.

Noom's site describes a four-step process for Noom Med: take a brief intake survey covering your health history and weight-loss goals, connect with a clinician who evaluates your results and prescribes online if clinically appropriate, get medication shipped to you if eligible, then keep unlimited access to your clinician and medication refills where clinically appropriate, as stated as of September 11, 2026. Its hero copy also says weight-loss medication is shipped in 7 days, if prescribed. For its Ozempic flow specifically, Noom's site adds a metabolic lab-test step between the intake survey and the clinician consult.

Noom states that not all medications are available for home delivery, and that availability depends on your insurance or cash-pay status.

Noom's FAQ, as of September 11, 2026, states you do not need insurance to use Noom Med. It says Noom supports members with and without insurance: if you have insurance, Noom says it will work to help maximize your coverage for medication and clinician services, and if you do not, you can access clinicians and medication through what it calls affordable cash-pay options. Noom's terms of use, updated December 9, 2025, add that Noom is not enrolled with Medicare, Medicaid or other federal or state healthcare programs, and that neither Noom nor its clinical partners will submit claims to those programs.

Noom's FSA/HSA eligibility badges appear on several plans, but its own disclosure states every FSA/HSA plan is unique and that Noom cannot guarantee any of its services will qualify for a given plan.

Noom's headline weight-loss figures are company-reported and come with specific caveats. Its site claims Noom Med members lose 48% more weight in 6 months than those taking a GLP-1 without Noom, and separately that Noom's habits help you lose 37% more weight on a GLP-1 than medication alone. The 37% figure is footnoted to a retrospective study of self-reported data and to a January 2026 analysis grouping members by how often they opened the app, which Noom says does not imply causation; neither is a controlled trial. The footnote marked on the 48% figure does not say how that figure was measured. Instead it gives a clinical-trial figure, 15% weight loss for Wegovy and 20% for Zepbound over 68 to 72 weeks, which applies only to those branded, FDA-approved medications, and it states the FDA does not review any compounded medication for safety or efficacy.

For its Microdose GLP-1Rx plan specifically, Noom footnotes a study of 3,562 members using self-reported data, in which the average expected weight loss for those who followed the titration protocol was 5.8 pounds, a smaller figure than the 'up to 17 pounds in 60 days' headline that same footnote is attached to.

Noom's terms of use, updated December 9, 2025, say paid plans renew on their own unless you cancel before your next billing date. To cancel, you log into your account and follow the instructions on your account page (if you subscribed through the Apple App Store or Google Play, that store's cancellation steps apply instead), and you must cancel before 11:59 p.m. Eastern time on the day before your next billing date to avoid the next charge. The same terms say Noom does not refund partially used billing periods except case by case at its discretion, and that outside a three-business-day right for California residents to rescind, fees are non-refundable unless a Noom promotion expressly says otherwise. The Microdose plan's own pricing footnote also states that plan can be canceled anytime.

Noom's Microdose GLP-1Rx pricing is also stated to apply to new accounts only as of July 27, 2026, and Noom's own footnote states the program is not available in all 50 states without naming which ones.

Noom Med may suit you if you want prescription weight-loss medication bundled with the coaching and habit-tracking tools of the main Noom app, and you are comfortable choosing between a pricier branded-medication route where insurance may cover part of the medication cost or a cheaper compounded route that Noom itself says is not FDA-approved. It may be worth looking elsewhere, or asking Noom directly before you sign up, if you want a refund option: Noom's terms say fees are generally not refundable, and its compounded-medication pricing changed for new accounts as recently as July 2026, as stated on its site as of September 11, 2026.

We don't currently list Noom Med in our rankings. This page carries no tracked links, and we earn nothing if you sign up.

Is Noom Med legit?

Noom Med is an operating clinical weight-loss program as of September 11, 2026, offering both FDA-approved brand-name medications and compounded medications through licensed clinicians. It publishes pricing for both routes and discloses, in its own footnotes, that compounded medications are not FDA-approved and that its 37% weight-loss claim comes from retrospective analyses rather than controlled trials. This review does not rate whether Noom is a good fit for you, only what it states about its own service.

Is Noom Med a good deal?

It depends on which route you take. As of September 11, 2026, Noom's Ozempic page listed $39 to get started, then $129 a month for ongoing care, before the separate cost of the medication itself, which Noom's own FAQ said can run $900 to $1,000 a month without insurance for Ozempic. Its compounded Microdose GLP-1Rx plan is cheaper up front, $79 for an initial three-week period, then $179 a month, but uses medication Noom states has not been FDA-reviewed for safety, efficacy or quality.

Does Noom Med take insurance?

Noom's FAQ, as of September 11, 2026, says you do not need insurance to use Noom Med. It states it supports members with and without insurance, working to help maximize coverage if you have it, or offering cash-pay access to clinicians and medication if you do not.

What is the downside of Noom Med?

Based on Noom's own site as of September 11, 2026, the clearest downsides are that its cheaper compounded medication is not FDA-approved as a finished product, its terms say fees are generally not refundable, its Microdose pricing changed for new accounts as of July 27, 2026, and its 37% weight-loss claim is footnoted to retrospective analyses rather than controlled clinical results, while the footnote on its 48% claim does not say how that figure was measured.

Is the medication in Noom's GLP-1 programs FDA-approved?

It depends on the plan. Noom's brand-name options, like Ozempic, Zepbound and Wegovy, are FDA-approved medications, though Noom states Ozempic is not FDA-approved for weight loss and may be prescribed off-label for it. Noom's Microdose GLP-1Rx and other Noom-branded GLP-1Rx programs use compounded semaglutide or tirzepatide, which Noom's own site states has not been reviewed by the FDA for safety, efficacy or quality, as of September 11, 2026.

Can you cancel Noom Med at any time?

Noom's terms of use, updated December 9, 2025, say you can cancel your subscription at any time before the end of the current billing period by logging into your account and following the instructions on your account page, and that you must cancel before 11:59 p.m. Eastern time on the day before your next billing date to avoid the next charge. Cancellation generally takes effect at the end of the current billing period. Noom's Microdose GLP-1Rx pricing footnote also states that plan can be canceled anytime, as of September 11, 2026.